Does pravastatin affect circulating levels of soluble TNF receptor 2 in hypercholesterolemic patients?
Ando
Hitoshi
H
Takamura
Toshinari
T
Kobayashi
Ken-ichi
K
Misu
Hirofumi
H
Osawa
Kenso
K
D000328:Adult; D001774:Blood Chemical Analysis; D008076:Cholesterol, HDL / Q000032:analysis / Q000187:drug effects; D008078:Cholesterol, LDL / Q000032:analysis / Q000187:drug effects; D003131:Combined Modality Therapy; D004035:Diet Therapy / Q000379:methods*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006937:Hypercholesterolemia / Q000175:diagnosis / Q000178:diet therapy* / Q000188:drug therapy*; D007564:Japan; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D017035:Pravastatin / Q000627:therapeutic use*; D011336:Probability; D011446:Prospective Studies; D018124:Receptors, Tumor Necrosis Factor / Q000032:analysis* / Q000187:drug effects*; D012044:Regression Analysis; D012995:Solubility; D018709:Statistics, Nonparametric; D016896:Treatment Outcome
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D018124:Receptors, Tumor Necrosis Factor; D017035:Pravastatin